What Aerobiotix does

Aerobiotix is a medical device company founded in 2013 and headquartered in Miamisburg, Ohio, that develops air disinfection systems for healthcare facilities. The company targets hospital-acquired infection (HAI) reduction through continuous air decontamination in operating rooms, intensive care units, and other clinical environments. Its installed base spans large integrated delivery networks (IDNs), academic medical centers, and federal healthcare facilities, including the VA health system.

The company's flagship product is the Illuvia Sense system, an FDA-registered Class II medical device that combines high-efficiency particulate air (HEPA) filtration with ultraviolet germicidal irradiation (UVGI) inside a proprietary Intraviolet photolytic chamber. The platform continuously monitors air quality via onboard sensors and is engineered to inactivate airborne pathogens without disrupting clinical workflows. Aerobiotix has invested in a peer-reviewed clinical evidence program, with published studies documenting reductions in microbial burden and surgical site infection rates at deploying institutions.

Aerobiotix pursues a capital-equipment-plus-recurring-consumables business model, selling devices to hospital systems while generating recurring revenue through replacement filters, maintenance contracts, and service agreements. The company goes to market through a combination of direct enterprise sales and healthcare group purchasing organizations (GPOs) and channel partners including Vizient, CapstoneHealth, and PartnersCooperative. Disclosed backers include Vivo Capital, Asahi Kasei Ventures, and Horizon Technology Finance, with cumulative disclosed funding of approximately $35 million raised between 2021 and 2022.

Name

Aerobiotix

Legal name

Aerobiotix USA, LLC

Website

https://aerobiotix.com

Company type

Private

Founded year

2013

Operating status

Operating

Headcount range

51–100 employees

Short description

Aerobiotix develops FDA-cleared medical-grade air disinfection systems for hospitals and surgical suites, combining HEPA filtration with UVGI photolytic chamber technology. It sells to U.S. IDNs, academic medical centers, and federal healthcare facilities via direct sales and GPO channels.

Ownership category

akta.pro rank

Product category

Medical Air Disinfection Systems

NAICS

Industrial and Commercial Fan and Blower and Air Purification Equipment Manufacturing (333413), Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113)

SIC

Industrial & Commercial Fans & Blowers & Air Purifing Equip (3564), Surgical & Medical Instruments & Apparatus (3841), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)

akta.pro primary industry

Air Quality & Environmental Infection Control (HEPA Filtration, Isolation Barriers, CSSD/HVAC Solutions) (HLAHANAK)

akta.pro secondary industries

Disinfection & Surface Decontamination (Wipes, Sprays, Fogging, UV Robots) (HLAHANAD), Healthcare Facility & Medical Office Disinfection (HSAEAHAC), Infectious Disease/Pathogen Decontamination (HSAEAHAF)

Keywords

• Medical air disinfection
• Surgical air purification
• HEPA filtration systems
• UVGI air treatment
• Hospital infection prevention

Headquarters

HQ city

Miamisburg

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Operations, Supply Chain, Personnel, Marketing or Sales, Infrastructure

Revenue model

1. Air Disinfection Hardware Sales: Sale of air disinfection devices (Illuvia Sense, AeroCure Vac, AeroCure 200, GermZone Pro) as capital equipment. Devices are FDA-registered Class II medical devices sold directly to healthcare facilities through enterprise sales motion, GPO contracts, and IDN partnerships. One-time capital purchase model.
2. Recurring Consumables & Service: Recurring revenue from disposable pre-filter cartridge replacements (daily), periodic HEPA filter replacement, and UV lamp replacement performed by Aerobiotix representatives. Routine exterior wipe-down with EPA-registered disinfectant is performed by facility staff.
3. Professional Services & Training: Competency-based staff training (approximately 30 minutes per session) included as part of implementation. Ongoing support from Aerobiotix Clean Air Consultants and sales representatives.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels16 records

Core offering

Aerobiotix designs, manufactures, and sells FDA-registered Class II medical air disinfection devices for hospitals and ambulatory surgery centers. The flagship Illuvia Sense system combines HEPA filtration, UVGI, and a proprietary Intraviolet photolytic chamber to continuously inactivate airborne bacteria, viruses, and spores in occupied operating rooms, with integrated real-time environmental sensing. Supporting products AeroCure Vac, AeroCure 200, and GermZone Pro extend air decontamination to other healthcare environments.

Product overview

Aerobiotix offers a suite of proprietary medical-grade air disinfection products for healthcare environments. The core product is the Illuvia Sense system, an FDA-registered Class II medical device that provides continuous air decontamination with real-time environmental monitoring for operating rooms. Supporting the platform are additional air decontamination products including AeroCure Vac, AeroCure 200, and GermZone Pro. All products utilize ultraviolet light technology, HEPA or ULPA filters, and proprietary Intraviolet core technology to remove 99.9% of bacteria, viruses, and spores. The products are designed to run continuously in occupied rooms to reduce infection risks and improve patient and staff well-being.

Differentiator

Problem solved

Functional benefit

Brands

• Illuvia Sense: Surgical air purification device with environmental sensing and reporting technologies, labeled for reducing risk of infection and improving environmental safety in operating rooms.
• AeroCure Vac
• AeroCure 200
• GermZone Pro

Products and services

• Illuvia Sense Illuvia Sense is an FDA-registered Class II medical device that provides continuous surgical air disinfection using HEPA filtration, ultraviolet germicidal irradiation (UVGI), and proprietary Intraviolet photolytic chamber technology. It delivers real-time environmental monitoring of particulate counts, temperature, humidity, door openings, CO2, and VOCs for operating rooms to reduce surgical site infections (SSIs) and improve environmental safety. Targets hospitals, ambulatory surgery centers, and surgical suites.
• AeroCure Vac AeroCure Vac is a hospital air disinfection system designed to eliminate airborne pathogens in healthcare facilities. Sold as part of Aerobiotix's hospital air decontamination product line.
• AeroCure 200 AeroCure 200 is an air decontamination device for healthcare environments, utilizing Aerobiotix's proprietary ultraviolet and HEPA filtration technology to remove airborne pathogens.
• GermZone Pro GermZone Pro is an air decontamination system for healthcare facilities, part of Aerobiotix's portfolio of UV- and HEPA-based disinfection devices.
• Recurring Consumables & Service (Pre-filter cartridges, HEPA filters, UV lamp replacement) Recurring revenue program delivering disposable pre-filter cartridge replacements (daily), periodic HEPA filter replacement, and UV lamp replacement performed by Aerobiotix representatives, plus routine exterior wipe-down with EPA-registered disinfectant. Bundled with device sales to support continuous operation of the air disinfection fleet.
• Professional Services & Training (Clean Air Consultants) Competency-based staff training (approximately 30 minutes per session) included as part of device implementation, plus ongoing support from Aerobiotix Clean Air Consultants and sales representatives for healthcare facilities deploying Illuvia Sense and supporting devices.

Quantifiable outcome

• Inactivates 99.9% of bacteria, viruses, and spores in the air
• +4 more outcomes

Named customers22 records

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature5 records

Partnerships

Seven partnerships are on record, tiered major, minor and core.

• Premier, Inc.majorChannel Partner/ Reseller/ Distributor · 16 March 2026Premier, Inc. awarded Aerobiotix USA, LLC a Technology Breakthrough Designation for Illuvia Sense, effective March 16, 2026. This designation enables Premier's member healthcare providers to access pre-negotiated pricing and terms for the infection prevention product. Premier is a leading healthcare improvement company operating a GPO serving thousands of US hospitals.
• CapstoneHealthminorChannel Partner/ Reseller/ DistributorListed as a GPO partner on Aerobiotix's Partnerships page, enabling member hospitals to procure Illuvia Sense through CapstoneHealth's group purchasing contracts.
• PartnersCooperativeminorChannel Partner/ Reseller/ DistributorListed as a GPO partner on Aerobiotix's Partnerships page, providing group purchasing contracting for member healthcare facilities.
• International Respiratory Infections Society (IRIS)majorStrategic or Co-development PartnerAerobiotix co-developed the IRIS Healthcare Air Quality Seal of Recognition Program with the International Respiratory Infections Society. This program recognizes healthcare facilities that exceed established air quality standards in operating rooms, powered by Aerobiotix technology. The program is featured on safehealthcareair.org and included in Aerobiotix's marketing materials as a core differentiator.
• AORN (Association of periOperative Registered Nurses)coreGTM or Marketing PartnerAerobiotix is a member of AORN and actively sponsors chapter CE events (Chicago, Silicon Valley, Northeast Florida, San Francisco Bay Area) on air quality management, CMS TEAM model, and AORN sterile technique guidelines. Company presents at AORN 2026 Global Conference in New Orleans.
• APIC (Association for Professionals in Infection Control and Epidemiology)coreGTM or Marketing PartnerAerobiotix is a member of APIC and sponsors chapter meetings and the APIC26 Annual Conference & Expo in Nashville. Educational content focuses on infection prevention, air quality management, and SSI reduction strategies.
• AHVAP (Association of Healthcare Value Analysis Professionals)coreGTM or Marketing PartnerAerobiotix is a corporate member of AHVAP and sponsors the AHVAP 2026 Annual Conference & Industry Partner Expo. AHVAP authored a professional position statement on product evaluation that Aerobiotix references in its value analysis selling motion.

Scale indicators3 records

Recent moves6 records

Expansion highlights4 records

Broad incumbents

• IQAir: IQAir manufactures high-performance HEPA air purifiers used in hospitals, cleanrooms, and clinical settings. It competes with Aerobiotix in healthcare-grade air purification, though it relies on HEPA-only filtration rather than Aerobiotix's combined UVGI + photolytic chamber approach.
• Steris: Steris is a global leader in infection prevention and sterilization, offering capital equipment and consumables to hospitals and surgical centers. It competes broadly with Aerobiotix in OR infection control via its sterilization and surface disinfection portfolio and represents a likely strategic acquirer.
• Halton Group: Halton provides indoor air solutions for healthcare, including operating room ventilation, ULPA filtration, and air distribution systems. It is a broader incumbent in the surgical air quality infrastructure category, offering engineered HVAC versus Aerobiotix's point-of-care medical device approach.
• Daikin Applied (Daikin Industries): Daikin Applied supplies commercial and healthcare HVAC systems, including filtration and air-handling units for hospital operating rooms. As a broad incumbent in OR ventilation, it represents the installed-base alternative to point-of-care devices like Aerobiotix's Illuvia Sense.

Direct peers

• Novaerus (Wellair): Novaerus (defunct brand Wellair) sells medical-grade plasma air disinfection units for healthcare and life science settings. It directly competes with Aerobiotix in operating rooms, ICUs, and patient rooms using an alternative (non-UV) air disinfection modality, making it the closest direct competitor.
• Abatement Technologies: Abatement Technologies manufactures HEPA-filtered air purification and negative-pressure containment equipment for healthcare facilities, including infection control during construction. It is comparable to Aerobiotix in addressing healthcare airborne pathogen control via portable HEPA-based devices.
• Xenex Disinfection Services: Xenex manufactures pulsed-xenon UV disinfection robots used in hospital rooms for pathogen reduction. While its modality (mobile UV robot) differs from Aerobiotix's continuous in-room UVGI, it competes for the same SSI/HAI reduction budget within infection prevention departments.
• AtmosAir Solutions: AtmosAir Solutions provides commercial and healthcare indoor air quality solutions, including bipolar ionization and HEPA-based systems deployed in hospitals. It overlaps with Aerobiotix in the healthcare air disinfection category with comparable target customers (IDNs, hospitals).
• PDI Healthcare (Tru-D SmartUVC): PDI's Tru-D SmartUVC platform provides UV-C disinfection for healthcare environments, primarily terminal room cleaning. It competes with Aerobiotix in the healthcare UV air/surface disinfection category, though it focuses more on room turnover than continuous in-OR air quality.
• Surgically Clean Air: Surgically Clean Air markets medical-grade HEPA + UV air purification systems explicitly for operating rooms and surgical centers. It competes head-to-head with Aerobiotix in the surgical air quality category with a similar multi-stage HEPA/UV value proposition.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights7 records

Customer concentration

• Xtwitter.com/AerobiotixLLC
• YouTubeyoutube.com/channel/UCfmhgqLym8Waxd9xIE3vMyQ/featured
• Facebookfacebook.com/Aerobiotix.Inc
• LinkedInlinkedin.com/company/aerobiotix-llc

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds2 records

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Aerobiotix